Wegovy (semaglutide) is approved to reduce the risk of serious heart problems in adults with obesity or overweight who have established heart disease
Manual validation ensured accurate identification of all amino acid residues and post-translational modifications. Nuclear Magnetic Resonance (NMR) Spectroscopy To complement mass spectrometric data, ^1H and ^13C NMR spectroscopy were performed, providing insights into the conformational aspects and confirming the presence of specific functional groups, particularly in modified regions. Quality Control and Batch-to-Batch Comparability Assessment (New Section) Beyond single-batch characterization, peptide sequencing plays a vital role in establishing batch-to-batch consistency during late-stage development
Well-Tolerated: While side effects are possible, many patients tolerate Semaglutide well, especially when starting with a low dose and gradually increasing it to the target dose
(2024, September) The article highlights the remarkable progress in GLP-1 receptor therapies, with semaglutide standing out for its powerful effects beyond glucose control (notably in weight loss, cardiovascular protection, and potential benefits for liver and brain health)
Most are gastrointestinal and occur as your body adjusts to the medicine